- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanometrics Incorporated (NASDAQ: NANO), a leading provider of advanced process control metrology systems, today announced financial results for its third quarter ended October 1, 2011.
Highlights for the quarter include:
- Revenues of $58.3 million, at the midpoint of guidance and down 9% from a record second quarter;
- Gross margin of 52.9%;
- $11.7 million of income from operations and 20.2% operating margin;
- Increase in cash and investments of $8.5 million, ending the quarter at $100.1 million;
- Receipt of a multiple-unit order for our first 450mm systems, scheduled for mid-2012 delivery to multiple sites;
- Continuing significant competitive wins, including the announced OCD tool-of-record selection from an emerging foundry customer based in Asia and the integrated metrology selection from a leading Flash memory company, as well as multiple UniFire purchases from leading logic and memory customers.
Commenting on the third quarter results, president and chief executive officer Dr. Timothy J. Stultz said, "In a challenging industry environment and rapidly changing business dynamics, we delivered a strong third quarter, in line with the guidance we provided in late July. As we entered the third quarter, we began to see shifting priorities in the semiconductor industry, evidenced by order push-outs and delays in planned capacity expansions. Even with the increased level of volatility, until the second half of August, we continued to expect a return to revenue growth in the fourth quarter. Over the past two months, however, customer forecasts and capital spending have declined precipitously, and we now expect to see a significant sequential decline in revenues for the fourth quarter. That being said, we believe that order rates are either at - or nearing - trough levels.
"We achieved a number of meaningful new competitive wins in the third quarter that continue to demonstrate the strength of our products and ability to execute. We are gaining share in nearly every growth market within process control metrology. While we are not immune to the current slowdown in capital spending, conversations with our customers as well as industry analysis suggests to us that the pause is temporary. We are in the midst of a significant change in the way solid-state devices are designed and manufactured. While the transitions from 65, 45 and 32 nanometer devices followed traditional rules of shrinking geometries, the move to 22nm and below requires new tools, techniques and increased capital intensity. These leading-edge devices are expected to see meaningful growth as they address customer demand for higher-performance, smaller, and less expensive chip designs.
"In consideration of the significant opportunities created by the disruptive technology changes within the semiconductor industry impacting the next several technology nodes, our newly-established and growing partnerships with the leading device manufacturers, and our focus on long-term value creation and performance, we intend to continue to drive hard on winning new business and increasing our footprint in the worldwide semiconductor manufacturing industry. Our leadership in 3D device structures and advanced packaging technologies enable our customers to meet their technology roadmaps, and our served markets are expected to outpace the overall industry through the next several years. We believe our continued focus and investments contribute to a strong outlook for our business and continued growth and outperformance in 2012 and beyond."
Third Quarter 2011 Summary
Revenues were $58.3 million, down 9% from a record $64.4 million in the second quarter of 2011 and up 8% from $53.9 million in the third quarter of 2010. Gross margin declined to 52.9%, compared to 56.1% in the prior quarter and 54.5% in the year-ago period, primarily as a result of product mix. Our operating margin was 20.2%, compared to 27.2% in the prior quarter and 25.6% in the year-ago period. Net income was $7.6 million or $0.32 per share, compared to $11.1 million or $0.47 per share in the prior quarter and $12.3 million or $0.53 per share in the third quarter of 2010.
At October 1, 2011, Nanometrics had $100.1 million in cash and cash equivalents and $176.7 million in working capital. Stockholders' equity, excluding intangible assets, was $201.5 million, or $8.78 per share based on 23.0 million shares outstanding at quarter end.
To view Q3-2011 tables, please visit www.nanometrics.com.
Due to the global economic slowdown and a significant pause in spending by the world's manufacturers of semiconductors, LEDs and other electronic devices, management expects revenues in the range of $40 to $44 million, gross margin in the range of 50% to 51% and operating income margin in the range of 1.5% to 6.5% for the fourth quarter of 2011. With an anticipated annual effective income tax rate of approximately 35%, management expects net earnings for the fourth quarter of 2011 in the range of $0.01 to $0.07 per diluted share.
Conference Call Details
A conference call to discuss third quarter results will be held today at 4:30 p.m. EDT (1:30 p.m. PDT). To participate in the conference call, the dial-in numbers are (877) 374-4041 for domestic callers and (253) 237-1156 for international callers. A live and recorded webcast will be made available on the investor page of the Nanometrics website at www.nanometrics.com.
Use of Non-GAAP Financial Information
Financial results such as non-GAAP operating income, which exclude certain expenses, charges and special items, are not in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Management uses non-GAAP operating income, which excludes non-cash expenses including stock-based compensation, depreciation and amortization, as well as asset impairments, restructuring charges and other special items, to evaluate the company's ongoing performance and cash flow from operations. The company believes the presentation of non-GAAP operating income is useful to investors for analyzing ongoing business trends, comparing performance to prior periods, and enhancing the investor's ability to view the company's results from management's perspective. A table presenting a reconciliation of GAAP results to non-GAAP operating income is included at the end of this press release.
About Nanometrics Incorporated
Nanometrics is a leading provider of advanced, high-performance process control metrology systems used primarily in the fabrication of semiconductors, high-brightness LEDs, data storage devices and solar photovoltaics. Nanometrics’ automated and integrated metrology systems measure critical dimensions, device structures, overlay registration, topography and various thin film properties, including film thickness as well as optical, electrical and material properties. The company’s process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced wafer-scale packaging applications. Nanometrics’ systems enable device manufacturers to improve yields, increase productivity and lower their manufacturing costs. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide. Nanometrics is traded on NASDAQ Global Select Market under the symbol NANO. Nanometrics’ website is www.nanometrics.com.
Forward Looking Statements
This press release contains forward-looking statements including, but not limited to, statements regarding Nanometrics’ expected results for its most recently completed fiscal quarter, which remain subject to adjustment in connection with the preparation of Nanometrics’ financial statements and periodic report on Form 10-Q for the quarter ended October 1, 2011, the continued adoption and competitiveness of its products, the expansion of the company’s served markets and market share, changes in semiconductor capital spending, and our outlook for future revenue, profitability and cash flow. Although Nanometrics believes that the expectations reflected in the forward-looking statements are reasonable, actual results could differ materially from the expectations due to a variety of factors including a contraction in current levels of industry spending, shifts in the timing of customer orders and product shipments, slower-than-anticipated market adoption, changes in product mix and increased operating expenses. For additional information and considerations regarding the risks faced by Nanometrics, see its annual report on Form 10-K for the year ended January 1, 2011 as filed with the Securities and Exchange Commission, as well as other periodic reports filed with the SEC from time to time. Nanometrics disclaims any obligation to update information contained in any forward-looking statement.
For more information, please click here
Investor Relations Contact:
Headgate Partners LLC
Copyright © Nanometrics IncorporatedIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
National Science Foundation Selects SUNY Poly CNSE for Expanded $2.1M Northeast Advanced Technological Education Center: NSF Center Locates to NanoCollege in Support of Flourishing Tech Industry in NYS September 1st, 2015
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
A little light interaction leaves quantum physicists beaming August 25th, 2015
Using DNA origami to build nanodevices of the future September 1st, 2015
Nanotech could rid cattle of ticks, with less collateral damage September 1st, 2015
Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015